Similar articles for PMID: 23815273

Year	Number of Results
1993	1
1998	1
1999	1
2000	1
2001	1
2002	1
2004	2
2005	1
2006	4
2007	2
2008	6
2009	4
2010	5
2011	6
2012	4
2013	10
2014	4
2015	18
2016	4
2017	4
2018	5
2019	5
2020	14
2021	15
2022	19
2023	3
2024	0

1

Modeling the public health impact of malaria vaccines for developers and policymakers.

Nunes JK, Cárdenas V, Loucq C, Maire N, Smith T, Shaffer C, Måseide K, Brooks A. Nunes JK, et al. BMC Infect Dis. 2013 Jul 1;13:295. doi: 10.1186/1471-2334-13-295. BMC Infect Dis. 2013. PMID: 23815273 Free PMC article.

2

Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models.

Penny MA, Verity R, Bever CA, Sauboin C, Galactionova K, Flasche S, White MT, Wenger EA, Van de Velde N, Pemberton-Ross P, Griffin JT, Smith TA, Eckhoff PA, Muhib F, Jit M, Ghani AC. Penny MA, et al. Lancet. 2016 Jan 23;387(10016):367-375. doi: 10.1016/S0140-6736(15)00725-4. Epub 2015 Nov 6. Lancet. 2016. PMID: 26549466 Free PMC article.

3

Estimated impact of RTS,S/AS01 malaria vaccine allocation strategies in sub-Saharan Africa: A modelling study.

Hogan AB, Winskill P, Ghani AC. Hogan AB, et al. PLoS Med. 2020 Nov 30;17(11):e1003377. doi: 10.1371/journal.pmed.1003377. eCollection 2020 Nov. PLoS Med. 2020. PMID: 33253211 Free PMC article.

4

Cost-effectiveness analysis of vaccinating children in Malawi with RTS,S vaccines in comparison with long-lasting insecticide-treated nets.

Seo MK, Baker P, Ngo KN. Seo MK, et al. Malar J. 2014 Feb 24;13:66. doi: 10.1186/1475-2875-13-66. Malar J. 2014. PMID: 24564883 Free PMC article.

5

Potential public health impact of RTS,S malaria candidate vaccine in sub-Saharan Africa: a modelling study.

Sauboin CJ, Van Bellinghen LA, Van De Velde N, Van Vlaenderen I. Sauboin CJ, et al. Malar J. 2015 Dec 23;14:524. doi: 10.1186/s12936-015-1046-z. Malar J. 2015. PMID: 26702637 Free PMC article. Clinical Trial.

6

Country specific predictions of the cost-effectiveness of malaria vaccine RTS,S/AS01 in endemic Africa.

Galactionova K, Tediosi F, Camponovo F, Smith TA, Gething PW, Penny MA. Galactionova K, et al. Vaccine. 2017 Jan 3;35(1):53-60. doi: 10.1016/j.vaccine.2016.11.042. Epub 2016 Nov 24. Vaccine. 2017. PMID: 27890400 Free article.

7

Cost-effectiveness of pneumococcal conjugate vaccination in Croatia.

Vučina VV, Filipović SK, Kožnjak N, Stamenić V, Clark AD, Mounaud B, Blau J, Hoestlandt C, Kaić B. Vučina VV, et al. Vaccine. 2015 May 7;33 Suppl 1:A209-18. doi: 10.1016/j.vaccine.2014.12.043. Vaccine. 2015. PMID: 25919163

8

Economic Impact of Introducing the RTS,S Malaria Vaccine: Cost-Effectiveness and Budget Impact Analysis in 41 Countries.

Sauboin C, Van Bellinghen LA, Van De Velde N, Van Vlaenderen I. Sauboin C, et al. MDM Policy Pract. 2019 Dec 10;4(2):2381468319873324. doi: 10.1177/2381468319873324. eCollection 2019 Jul-Dec. MDM Policy Pract. 2019. PMID: 31853505 Free PMC article.

9

Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.

Baral R, Levin A, Odero C, Pecenka C, Tabu C, Mwendo E, Bonsu G, Bawa J, Dadzie JF, Charo J, Antwi-Agyei KO, Amponsa-Achianou K, Jalango RE, Mkisi R, Gordon S, Mzengeza T, Morgan W, Muhib F. Baral R, et al. PLoS One. 2021 Jan 11;16(1):e0244995. doi: 10.1371/journal.pone.0244995. eCollection 2021. PLoS One. 2021. PMID: 33428635 Free PMC article.

10

Simulated impact of RTS,S/AS01 vaccination programs in the context of changing malaria transmission.

Brooks A, Briët OJ, Hardy D, Steketee R, Smith TA. Brooks A, et al. PLoS One. 2012;7(3):e32587. doi: 10.1371/journal.pone.0032587. Epub 2012 Mar 6. PLoS One. 2012. PMID: 22412892 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

129 results

Results by year